Immunotargeting With CD154 (CD40 Ligand) Enhances DNA Vaccine Responses in Ducks

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00080-06
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2017English

Humoral Immune Responses in CD40 Ligand-Deficient Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
1994English

A Role for CD40-CD40 Ligand Interactions in the Generation of Type 1 Cytokine Responses in Human Leprosy

Journal of Immunology
AllergyImmunology
2000English

Soluble CD40 Ligand in Dementia

Drugs of the Future
Pharmacology
2009English

Soluble CD40 Ligand in Acute Coronary Syndromes

ACC Current Journal Review
2003English

Soluble CD40 Ligand in Morbidly Obese Patients

JAMA Surgery
Surgery
2013English

P19-44. Priming With a DNA Vaccine Enconding HIV CD4+ T Cell Epitopes Enhances Responses Against Subsequent Immunization With Plasmid Encoding Vif

Retrovirology
VirologyInfectious Diseases
2009English

Functional CD40 Ligand Is Expressed on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages: Implications for CD40-CD40 Ligand Signaling in Atherosclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A Promising Vaccine Strategy Against Flavivirus in Ducks

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy